New York Comprehensive Thalassemia Center
Found 2 results
Author Title Type [ Year(Asc)]
Filters: Author is Kattamis, Antonis  [Clear All Filters]
2022
Badawy SM, Kattamis A, Ezzat H, Deschamps B, Sicard E, Fradette C, Zhao F, Tricta F, Tsang YChung, Sheth S et al..  2022.  The safety and acceptability of twice-daily deferiprone for transfusional iron overload: A multicentre, open-label, phase 2 study.. Br J Haematol. 197(1):e12-e15.
2021
Frangoul H, Altshuler D, M Cappellini D, Chen Y-S, Domm J, Eustace BK, Foell J, de la Fuente J, Grupp S, Handgretinger R et al..  2021.  CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.. N Engl J Med. 384(3):252-260.